Investing.com - Carl Zeiss Medi-Exch reported on Friday fourth quarter earnings that matched analysts' forecasts and revenue that fell short of expectations.
Carl Zeiss Medi-Exch announced earnings per share of €0.7 on revenue of €477.4M. Analysts polled by Investing.com anticipated EPS of €0.7 on revenue of €477.42M.
Carl Zeiss Medi-Exch shares are down 31% from the beginning of the year, still down 36.91% from its 52 week high of €202.00 set on September 17, 2021. They are under-performing the STOXX 600 which is down 13.83% from the start of the year.
Carl Zeiss Medi-Exch follows other major Healthcare sector earnings this month
Carl Zeiss Medi-Exch's report follows an earnings beat by Merck on Friday, who reported EPS of €2.64 on revenue of €5.57B, compared to forecasts EPS of €2.51 on revenue of €5.42B.
Carl Zeiss AG had matched expectations on Friday with fourth quarter EPS of €0.7 on revenue of €477.4M, compared to forecast for EPS of €0.7 on revenue of €477.42M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar